Cramer and Wedbush are no different then UBS or others.They work for their bosses too.The truth of the street article is that Insmed has released very little of the data of the cystic fibrosis trial results almost 9 moths ago.
Accelerated approval for NTM if the results are good,but what is good? CF regular review in EU only
with a higher risk in April.
$30 or 10 .I am in for the bet.
Insmed is not going to file but they are talking with the FDA and MAY be able to convince them if NTM results are good
Did you like Wedbush when they were Insmeds #1 fan? They are no different from 100s of brokerages that do their bosses bidding
sold but +1.53 profit in 3 days. Sell on the news of a delay? 2% lower from yesterdays 10 up is safe bet
Bet it is not a 'huge vol day.This update news has been known. I bought last week 16.45.May sell if they push it down now.GLTA
slow and steady. Do not think it will have that much of an effect Resident basher is correct on a delay.Getting a drug to market takes an eternity.
What difference does it make?The UBS downgrade was a fake but was planted on the internet.Today was short covering and it would not surprise me that worse then the UBS internet story is a very possible collusion between 2 brokerages to attack short and then cover.
Piper Jaffray wants out now?.When do you ever see a firm say a triple! 8200 volume @18
SEC doc show that most of the 3 M RA dumped was bought by 2 others. RA capital ? Were they one of the originals? Why now is the question.